REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BerganKDV Wealth Management, LLC | 38 | $962 | 0.00% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 33,312 | $843,127 | 0.00% |
| CENTRAL TRUST Co | 50 | $1,266 | 0.00% |
| STIFEL FINANCIAL CORP | 14,256 | $360,818 | 0.00% |
| Strategic Investment Solutions, Inc. /IL | 50 | $1,182 | 0.00% |
| Walleye Trading LLC | 2,500 | $63,275 | 0.00% |
| Walleye Trading LLC | 107 | $2,708 | 0.00% |
| Covestor Ltd | 7 | $0 | 0.00% |
| PICTET ASSET MANAGEMENT SA | 8,991 | $227,562 | 0.00% |
| Point72 Asset Management, L.P. | 3,100 | $78,461 | 0.00% |
| BANK OF MONTREAL /CAN/ | 43,077 | $1,265,399 | 0.00% |
| LPL Financial LLC | 23,772 | $601,669 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 25,502 | $645,456 | 0.00% |
| Versant Capital Management, Inc | 14 | $354 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 1,040 | $26,291 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 114 | $2,885 | 0.00% |
| ASSETMARK, INC | 1,996 | $50,519 | 0.00% |
| Citadel Advisors | 52,100 | $1,318,651 | 0.00% |
| Citadel Advisors | 59,299 | $1,500,858 | 0.00% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q2 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.